Prednisolone does not prevent the occurrence of nevirapine-induced rashes.
Rey
D
D
Partisani
M
M
Krantz
V
V
Kempf
G
G
Nicolle
M
M
de Mautort
E
E
Priester
M
M
Bernard-Henry
C
C
Lang
J M
JM
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003875:Drug Eruptions / Q000188:drug therapy*; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D019829:Nevirapine / Q000009:adverse effects* / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use*; D012189:Retrospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*
D019380:Anti-HIV Agents; D000893:Anti-Inflammatory Agents; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine; D011239:Prednisolone